Palogic Value Management L.P. purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 4,395 shares of the company’s stock, valued at approximately $565,000.
A number of other hedge funds have also modified their holdings of the stock. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA during the second quarter worth $25,000. Rakuten Securities Inc. purchased a new position in Merck KGaA in the second quarter valued at about $27,000. Delos Wealth Advisors LLC purchased a new position in Merck KGaA in the second quarter valued at about $33,000. Solstein Capital LLC acquired a new position in Merck KGaA in the 2nd quarter worth about $33,000. Finally, Burk Holdings LLC acquired a new position in Merck KGaA in the 2nd quarter worth about $39,000. 0.10% of the stock is owned by institutional investors and hedge funds.
Merck KGaA Stock Up 0.4%
MKGAF opened at $164.58 on Thursday. The company has a market capitalization of $21.27 billion, a PE ratio of 25.13 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56. The business has a 50-day moving average of $163.19 and a 200-day moving average of $148.83.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
